🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT07715500
Recruiting

Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications

NCT07715500 · tracked via the Priya Life Science India tracker
Sponsor
Institute of Liver and Biliary Sciences, India
Phase
N/A
Started
2025-07-01
Last updated
2026-07-20

Condition(s) studied

Chronic Liver Disease and CirrhosisLiver Transplant; ComplicationsDonor Hepatectomy

Investigational drug(s) / intervention(s)

Magnetic Resonance Cholangiopancreatography

Magnetic Resonance Cholangiopancreatography: Magnetic Resonance Cholangiopancreatography is being excluded from list of Investigation as part of Non inferiority trial

Study summary

Living donor liver transplantation is widely accepted as an life-saving treatment for patients with end-stage liver diseases. Careful donor selection is essential to maximize the success and minimize the risk of postoperative complications in donors and recipients. Mapping of biliary anatomy is one of the critical assessments for donor selection and surgical planning ,Biliary reconstruction is considered as the "Achilles heel" of liver transplantation and adequate imaging assessment of biliary anatomy can largely benefit the biliary anastomosis. Preoperative imaging assessment of biliary anatomy is good for the selection of donors but may not indispensable for surgical planning and Intraoperative confirmative assessment of biliary anatomy with IOC was essential

Eligibility

Sex
ALL
Min age
18 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * All prospective voluntary healthy liver donor of age 18-55 Exclusion Criteria: * Type C/D Portal vein anatomy * Left sided Gallbladder * Right Posterior Graft * Recipients undergoing Hepaticojejunostomy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
ILBS New Delhi India Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07715500 on ClinicalTrials.gov ↗ ← All trials in India